SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cardiome -- CRME -- Ignore unavailable to you. Want to Upgrade?


To: keokalani'nui who wrote (48)8/1/2006 11:08:47 PM
From: rareearth42  Respond to of 285
 
Wilder,

I think I recall you discussing it with me in the past, but I couldn't remember when.

Right now, I'm looking ahead to the PTN trial results, which will make me very happy if positive and the price rises accordingly, as people come to believe the drug.

I sure hope they're not late again with trial results, but they released an interim press announcement just a few months ago, which stated the trials were fully enrolled and should end with topline results around the end of August or early Sept.

I own most of the PTN $2.50 October calls outstanding, to minimize the investment and risk associated with the trial results but still with the possibility of a significant reward.

Let's hope for the best!

RE42



To: keokalani'nui who wrote (48)8/31/2006 2:15:57 PM
From: dr.praveen  Read Replies (1) | Respond to of 285
 
Nice to see you guys are wrong:-)Kidding...Any expectations if the 600mg dose will improve efficacy? My guess is it won't increase by much or it might be the same.

Cheers,
Praveen